Narrow your search

Library

LUCA School of Arts (5)

Odisee (5)

Thomas More Kempen (5)

Thomas More Mechelen (5)

UCLL (5)

VIVES (5)

KU Leuven (4)

ULB (3)

ULiège (3)

VDIC (3)

More...

Resource type

book (5)


Language

English (4)

German (1)


Year
From To Submit

2017 (1)

2012 (1)

2008 (1)

2006 (1)

2005 (1)

Listing 1 - 5 of 5
Sort by

Book
From inflammation to cancer : advances in diagnosis and therapy for gastrointestinal and hepatological diseases
Authors: ---
ISBN: 1283635933 9814343609 9789814343602 9781283635936 661394839X 9786613948397 9814343595 9789814343596 Year: 2012 Publisher: Hackensack, NJ : World Scientific,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Inflammation and cancer are two major disorders that cause huge concerns in our society. However, what one may not know is that both diseases are closely associated and, in particular, both occur in the gastrointestinal tract and liver. This book describes the mechanics of how inflammation can progress to cancer in these organs. The authors in this book comprehensively discuss the different biomarkers for early diagnosis, and current therapeutic treatments for these diseases. All of these would allow us to better understand the pathogenesis of both diseases. As such, this book provides compreh


Book
Gastroenterologische Infektiologie
Authors: ---
ISBN: 3110463784 3110464756 9783110464757 9783110463781 9783110464764 3110464764 9783110463675 3110463679 Year: 2017 Publisher: Berlin, [Germany] ; Boston, [Massachusetts] : De Gruyter,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Gastrointestinal infectious diseases are attracting greater attention because of issues of resistance, rising comorbidity, the susceptibility to infection of an aging population, and the problem of infectious diseases associated with migration. High-level medicine places strong requirements on managing complications and preventing infections. Microbiome research promises new approaches to the treatment of gastrointestinal infections. Infektionskrankheiten sind ein stetig wichtiger werdender Bestandteil der Gastroenterologie, werden in der Fort- und Weiterbildung aber bislang noch häufig vernachlässigt. Die gastroenterologische Infektiologie erfährt derzeit einen rasanten Bedeutungszuwachs durch die weitreichenden Resistenzprobleme infolge des häufig ungezielten Einsatzes von Antibiotika (insbesondere MRGN), der zunehmenden Herausforderung einer alternden Bevölkerung mit steigender Komorbidität und Infektionsanfälligkeit sowie durch die besonderen Herausforderungen von migrationsassoziierten Infektionskrankheiten. Komplexe Interventionen in der Hochleistungsmedizin mit ihren spezifischen Infektionsrisiken stellen besondere Anforderungen an das Komplikationsmanagement und die Infektionsprävention. Nicht zuletzt dürfte auch die Mikrobiomforschung neue Ansätze für das Krankheitsverständnis und die Therapiemöglichkeiten von gastrointestinalen Infektionen generieren, wie der bereits als Behandlungsoption bei rezidivierender Clostridium difficile-Infektion etablierte fäkale Mikrobiomtransfer zeigt.

Inflammatory Bowel Disease : From Bench to Bedside
Authors: --- ---
ISBN: 0387258078 9786610902347 1280902345 0387258086 Year: 2005 Publisher: New York, NY : Springer US : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Inflammatory Bowel Disease: From Bench to Bedside is a detailed and comprehensive story of the local and systemic pathophysiology of intestinal inflammation including management strategies. Research advances and current concepts of etiopathogenesis in the context of what is already known of the clinicopathologic features of these disorders are explored. This volume blends recent advances in the basic and clinical sciences as they relate to inflammatory bowel disease and emphasizes the effectiveness of a team approach of basic scientists and clinician investigators in this field.

Inflammatory Bowel Disease and Familial Adenomatous Polyposis : Clinical Management and Patients' Quality of Life
Author:
ISBN: 1280804963 9786610804962 8847004349 8847004330 Year: 2006 Publisher: Milano : Springer Milan : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Inflammatory bowel disease (IBD) and familial adenomatous polyposis (FAP) are complex diseases, which are subject to numerous medical researches. Despite increased knowledge on the pathophysiological process, many aspects remain rather unclear, especially concerning IBD. The genetic basis of FAP is well known, but there is still debate about IBD, which seems more likely to be a multifactorial disease, where the illness is due to interactions between environmental and genetic factors. In the near future, the aim will be to prevent these disorders and their sequelae through early detection and early intervention (for example genetic therapy). Unfortunately, we are still dealing with young patients with a lifelong disease course, leading to early morbidity (and in some cases mortality) and extended needs for medical treatment, with a consequent decrease in quality of life. IBD and FAP represent a challenge for a multidisciplinary medical approach where different personnel play major roles in different stages of the patient’s treatment. It is in this light that basic scientists, geneticists, pathologists, radiologists, gastroenterologists, surgeons, psychologists and WOC/ET nurses have to work together in order to improve the outlook of these patients and their families.


Book
Pediatric inflammatory bowel disease
Authors: --- ---
ISBN: 9780387734804 0387734805 9786611137489 1281137480 0387734813 Year: 2008 Publisher: New York, NY : Springer US : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Pediatric Inflammatory Bowel Diseases (IBD) are the most common and most significant chronic disorders in Pediatric Gastroenterology. The onset of Crohn disease and ulcerative colitis in the first two decades of life presents a number of diagnostic and therapeutic challenges that are unique to pediatric patients. Although the studies available for pediatric diagnosis have improved dramatically in the past three decades, the improvement in technology alone cannot account for the increased frequency of IBD recognized in early childhood. While therapy for older patients has improved dramatically with the use of immunomodulators and the development of exciting biologic strategies, rarely if ever have comprehensive studies of the pharmacokinetics, safety and efficacy of any of the IBD medications been performed in pediatric patients. A number of excellent medications are not available in liquid preparations that can be swallowed by children, and others, such as timed-release formulations, are developed for delivery to an adult gastrointestinal tract. It is unfortunate that the care we provide to children is often an extrapolation of what is known about and available for adults with IBD. Pediatric patients with IBD face a number of unique challenges. The onset of disease before puberty can be devastating. Growth failure is a particularly difficult problem with potentially permanent consequences. Much of the pediatric specific research has focused on the role of nutritional therapy to treat growth failure and induce remission.

Listing 1 - 5 of 5
Sort by